Report on main progress of acute lymphoblastic leukemia in the 54th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2012.12.002
- VernacularTitle:第54届美国血液学会年会急性淋巴细胞白血病研究领域的主要进展报道
- Author:
Bing XU
;
Hongsheng ZHOU
;
Xutao GUO
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphoblastic,acute;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2012;21(12):706-708
- CountryChina
- Language:Chinese
-
Abstract:
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease affected by patient' s age,immunologic subtype,genetic and molecular features.In the 54th ASH annual meeting,lots of new discoveries about the biology,prognosis and treatment of ALL were reported.Here highlights of genomic profiling,new targeted therapy and hematopoietic stem cell transplantation for ALL presented in this meeting are introduced.
